21 Years of Experience
Who is Dr. Chang, Radiation Oncologist in Ann Arbor, MI?
Dr. Daniel Chang, MD is a Radiation Oncologist, who primarily practices in Ann Arbor, MI with 2 additional practice locations. He has been practicing for over 21 years and is board certified by the American Board of Radiology. Dr. Chang completed his residency at University of Florida. Dr. Chang is fluent in English, and is currently seeing new patients. Dr. Chang’s practice accepts Medicaid, Medicare, UnitedHealthcare and other major insurance plans. To book an appointment or to confirm insurance options, please call Dr. Chang’s office at (650) 736-7143.
Where did Dr. Chang go to medical school and complete their residency?
Residency: University of Florida
Is Dr. Chang board certified in Radiation Oncologist?
Yes, Dr. Daniel Chang, MD is board certified by the American Board of Radiology since 2008
What languages does Dr. Chang speak?
Dr. Chang and their clinical team can communicate with patients in the following languages:
English
What conditions does Dr. Chang treat?
As a Radiation Oncologist, Dr. Chang diagnoses, treats, and manages a wide range of conditions. This condition information is derived from anonymized insurance claims and highlights the medical conditions most commonly treated by Dr. Chang. It provides insight into the doctor’s areas of experience and expertise based on real-world patient encounters from the past two years, updated quarterly.
Also known as:
- Liver Cancer
- Cancer Spread to Liver and Bile Duct
- Childhood Liver Cancer
- Hepatic Cancer
- Hepatocellular Carcinoma
- Metastatic Liver Cancer
- Secondary Liver Tumor
- Liver Metastasis
ICD-10 Codes:
- C220: Liver cell carcinoma
- C787: Secondary malignant neoplasm of liver and intrahepatic bile duct
Also known as:
- Secondary Bone Cancer
- Secondary Brain Cancer
- Cancer in Abdominal Lymph Nodes
- Secondary Cancer (Other Specified Sites)
- Cancer Follow-up Exam
- Bone Cancer
- Brain Tumor
- Cancer
- Metastatic bone cancer
- Cancer spread to bone
- Bone metastases
- Metastatic brain cancer
- Brain metastases
- Cancer spread to brain
- Metastatic Abdominal Lymph Node Cancer
- Secondary Intra-abdominal Lymphoma
- Abdominal Lymph Node Metastasis
- Metastatic cancer
- Cancer spread to other organs
- Cancer metastases
- Post-cancer treatment checkup
- Malignancy surveillance
- Oncology follow-up
ICD-10 Codes:
- C7951: Secondary malignant neoplasm of bone
- C7931: Secondary malignant neoplasm of brain
- C772: Secondary and unspecified malignant neoplasm of intra-abdominal lymph nodes
- C7989: Secondary malignant neoplasm of other specified sites
- Z08: Encounter for follow-up examination after completed treatment for malignant neoplasm
Also known as:
- Colorectal Cancer
- Rectal cancer
- Colon cancer
- Bowel cancer
- Malignant neoplasm of rectum
- Colon Cancer
- Rectal Cancer
- Bowel Cancer
- Colorectal Carcinoma
- Malignant neoplasm of colon
- Malignant neoplasm of sigmoid colon
ICD-10 Codes:
- C20: Malignant neoplasm of rectum
- C19: Malignant neoplasm of rectosigmoid junction
- C189: Malignant neoplasm of colon, unspecified
- C187: Malignant neoplasm of sigmoid colon
Also known as:
- Pancreatic Cancer
- Cancer of the pancreas
- Malignant neoplasm of pancreas
- Pancreatic adenocarcinoma
- Pancreas Cancer
- Malignant Pancreatic Tumor
- Pancreatic Carcinoma
ICD-10 Codes:
- C250: Malignant neoplasm of head of pancreas
- C259: Malignant neoplasm of pancreas, unspecified
Also known as:
- Esophageal Cancer
- Esophagus Cancer
- Malignant Neoplasm of Esophagus
- Gullet Cancer
- Esophageal Carcinoma
ICD-10 Codes:
- C155: Malignant neoplasm of lower third of esophagus
- C159: Malignant neoplasm of esophagus, unspecified
Also known as:
- Bile Duct Cancer
- Liver Cancer
- Cholangiocarcinoma
- Intrahepatic cholangiocarcinoma
ICD-10 Codes:
- C221: Intrahepatic bile duct carcinoma
Also known as:
- Prostate Cancer
- Prostate Cancer Treatment (PDQ®)
- Prostatic Carcinoma
- Prostate Gland Cancer
- Malignant Prostate Tumor
ICD-10 Codes:
- C61: Malignant neoplasm of prostate
Also known as:
- Secondary Cancer in Head and Neck Lymph Nodes
- Cancer
- Metastatic Cancer to Neck Lymph Nodes
- Head and Neck Lymph Node Cancer Spread
- Lymph Node Metastasis in Neck
ICD-10 Codes:
- C770: Secondary and unspecified malignant neoplasm of lymph nodes of head, face and neck
Also known as:
- Neuroendocrine Tumor
- Cancer
- Endocrine Disease
- Malignant NET
- Neuroendocrine Cancer
- NET Cancer
ICD-10 Codes:
- C7A8: Other malignant neuroendocrine tumors
Also known as:
- Stomach Cancer
- Gastric Cancer
- Stomach Carcinoma
- Cardia Cancer
ICD-10 Codes:
- C160: Malignant neoplasm of cardia
Which procedures does Dr. Chang perform as a Radiation Oncologist?
As a Radiation Oncologist, procedures performed by a Dr. Daniel Chang may include:
- Abdominal Aortic Aneurysm (AAA) Screening
- Abdominal Imaging
- Abdominal Radiology Consultation
- Angiography
- Arthrography
- Barium Swallow
- Bone Biopsy
- Bone Density Measurement / DXA Scan
For detailed information, please contact Dr. Chang's office.
Does Dr. Chang accept my insurance?
Dr. Chang accepts most major insurance plans. Important: Please call our office at (650) 736-7143 before your appointment to verify that your specific plan and network are accepted.
What insurance plans does Dr. Chang accept in Ann Arbor, MI?
Dr. Chang in Ann Arbor, MI accepts plans from many carriers. While this list is updated regularly, it is not a guarantee of coverage.
Top Insurances
All Other Third Party
Blue Cross Blue Shield of Michigan
CVS Health (formerly Aetna)
Health Alliance Plan (HAP)
Humana
McLaren Health Plan
Medicare
Molina
Spectrum / Priority Health
UnitedHealthcare
View All Insurances
Where is Dr. Chang's office located?
Dr. Daniel Chang's Primary Practice
1500 E Medical Center Dr
Ann Arbor, MI 48109
(650) 736-7143
Recognitions
Publications
Stereotactic Body Radiotherapy in the Treatment of Pancreatic Cancer
SEMIRS IN RADIATION ONCOLOGY, 2014
Combined-modality Therapy for Rectal Cancer Alysis of Potential Differences in Disease Presentation
AMERICAN JOURL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2014
Impact of chemotherapy on normal tissue complication probability models of acute hematologic
Intertiol jourl of radiation oncology, biology, physics, 2013
Safety of (90)y radioembolization in patients who have undergone previous exterl beam radiation
Intertiol jourl of radiation oncology, biology, physics, 2013
Radiotherapy for nodenoid cystic carcinomas of major salivary glands.
American jourl of otolaryngology, 2013
Seventh Edition (2010) of the AJCC
ANLS OF SURGICAL ONCOLOGY, 2013
A Phase 2 Multi-institutiol Study to Evaluate Gemcitabine
Practical radiation oncology, 2013
Dosimetric alysis of organs at risk during expiratory gating
Intertiol jourl of radiation oncology, biology, physics, 2013
Chemoradiotherapy Before and After Surgery for Locally Advanced Esophageal Cancer
Anls of surgical oncology
Metabolic Tumor Volume Predicts Disease Progression
JOURL OF NUCLEAR MEDICINE, 2013
Signet Ring Cell Colorectal Carcinoma
The American jourl of surgical pathology
Clinicopathologic Features of Synchronous Colorectal Carcinoma
The American jourl of surgical pathology
Intrafraction Verification of Gated RapidArc by Using Beam-Level Kilovoltage X-Ray Images
INTERTIOL JOURL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012
Prognostic Value of Metabolic Tumor Volume and Velocity in Predicting Head-and-Neck Cancer Outcomes
INTERTIOL JOURL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012
Combined Modality Therapy for Rectal Cancer
ANLS OF SURGICAL ONCOLOGY, 2012
A phase II multi-institutiol study to evaluate gemcitabine
Herman, J. M., Chang, D. T., Goodman, K. A., Wild, A. T., Laheru, D.,
Intensity-Modulated Radiotherapy for Tumors of the sal Cavity and Parasal Sinuses
Wiegner, E. A., Daly, M. E., Murphy, J. D., Abelson, J., Chapman, C. H, 2012
BRAF-mutated, Microsatellite-stable Adenocarcinoma of the Proximal Colon
AMERICAN JOURL OF SURGICAL PATHOLOGY, 2012
Combined-modality Therapy for Rectal Cancer
American jourl of clinical oncology
SINGLE-FRACTION STEREOTACTIC BODY RADIATION THERAPY AND SEQUENTIAL GEMCITABINE FOR THE TREATMENT OF
INTERTIOL JOURL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011
Stereotactic Body Radiotherapy for Colorectal Liver Metastases A Pooled Alysis
CANCER, 2011
Intensity-Modulated Radiation Therapy Versus Conventiol Radiation Therapy for Squamous Cell
CANCER, 2011
INTENSITY-MODULATED RADIOTHERAPY FOR ORAL CAVITY SQUAMOUS CELL CARCINOMA
INTERTIOL JOURL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011
PROSPECTIVE RANDOMIZED DOUBLE-BLIND PILOT STUDY OF SITE
INTERTIOL JOURL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011
Pattern of Lymph Node Involvement and Prognosis in Pancreatic Adenocarcinoma
AMERICAN JOURL OF SURGICAL PATHOLOGY, 2011
INTENSITY-MODULATED RADIOTHERAPY FOR LOCALLY ADVANCED CANCERS OF THE LARYNX AND HYPOPHARYNX
HEAD AND NECK-JOURL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND N, 2011
Gastrointestil Normal Tissue Toxicity Prediction In Stereotactic Body Radiotherapy
Murphy, J. D., Abelson, J., Chung, M. P., Chang, D. T., Koong, A. C., 2011
Stereotactic Body Radiation Therapy for Gastrointestil Maligncies
IMRT IGRT SBRT- ADVANCES IN THE TREATMENT PLANNING AND DELIVERY OF RAD, 2011
A DOSIMETRIC MODEL OF DUODEL TOXICITY AFTER STEREOTACTIC BODY RADIOTHERAPY FOR PANCREATIC CANCER
Murphy, J. D., Christman-Skieller, C., Kim, J., Dieterich, S., Chang, , 2010
Comparison of Intensity-Modulated Radiotherapy
Minn, A. Y., Hsu, A., La, T., Kunz, P., Fisher, G. A., Ford, J. M., No, 2010
(18)FLUORODEOXYGLUCOSE PET IS PROGNOSTIC OF PROGRESSION
INTERTIOL JOURL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010
INTENSITY-MODULATED RADIOTHERAPY IN THE TREATMENT OF OROPHARYNGEAL CANCER
INTERTIOL JOURL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010
EUS-guided gold fiducial insertion for image-guided radiation therapy of pancreatic cancer
GASTROINTESTIL ENDOSCOPY, 2010
INTERFRACTIOL UNCERTAINTY IN THE TREATMENT OF PANCREATIC CANCER WITH RADIATION
INTERTIOL JOURL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010
Stereotactic Body Radiotherapy for Colorectal Liver Metastases: A Pooled Alysis
Chang, D. T., Swamith, A., Kozak, M., Weintraub, J., Koong, A. C., Kim, 2010
Combined Modality Therapy for Rectal Cancer
Liauw, S., Song, S., Tonlaar, N., Hong, J. C., Minsky, B. D., Chang, D, 2010
Significant Duodel Dose Variation within the Respiratory Cycle during Stereotactic Body
Taniguchi, C. M., Kielar, K. N., Murphy, J. D., Atwood, T. F., Christm, 2010
Comparison of RapidArc vs. Conventiol Intensity Modulated Radiation Therapy
Kielar, K. N., Atwood, T. F., Taniguchi, C. M., Christman-Skieller, C., 2010
Intensity Modulated Radiation Therapy vs. Conventiol Radiation Therapy
Bazan, J. G., Hara, W., Kunz, P., Fisher, G. A., Ford, J. M., Welton, , 2010
Identification of a biomarker panel using a multiplex proximity ligation
JOURL OF TRANSLATIOL MEDICINE, 2009
Pancreatic Tumor Motion on a Single Planning 4D
AMERICAN JOURL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2009
Treatment of Esophageal Cancer Based on Histology A Surveillance Epidemiology
AMERICAN JOURL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2009
Long-term Outcomes for Stage I-II Aggressive Non-Hodgkin Lymphoma of Waldeyer's Ring
AMERICAN JOURL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2009
Percutaneous Implantation of Fiducial Markers for Imaging-Guided Radiation Therapy
AMERICAN JOURL OF ROENTGENOLOGY, 2009
Xerostomia in Long-term Survivors of Aggressive Non
AMERICAN JOURL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2009
Safety and Efficacy of Percutaneous Fiducial Marker Implantation for Image-guided Radiation Therapy
JOURL OF VASCULAR AND INTERVENTIOL RADIOLOGY, 2009
Do pre-irradiation dental extractions reduce the risk of osteoradionecrosis of the mandible?
HEAD AND NECK-JOURL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND N, 2007
Long-term outcomes in breast cancer patients with ten or more positive axillary nodes treated with
INTERTIOL JOURL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2007
Predicting changes in dose distribution to tumor
AMERICAN JOURL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2007
Adjuvant radiotherapy for cutaneous melanoma: Comparing hypofractiotion to conventiol fractiotion
INTERTIOL JOURL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2006
The impact of heterogeneity correction on dosimetric parameters that predict
INTERTIOL JOURL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2006
Re-examining the role of elective nodal irradiation
AMERICAN JOURL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2005
Merkel cell carcinoma of the skin with leptomeningeal metastases
AMERICAN JOURL OF OTOLARYNGOLOGY, 2005
Dose-dependent effects of D-damaging agents on p53-mediated cell cycle arrest
CELL GROWTH & DIFFERENTIATION, 1999
Stereotactic Body Radiotherapy in the Treatment of Pancreatic Cancer
SEMINARS IN RADIATION ONCOLOGY, 2014
Combined-modality Therapy for Rectal Cancer Analysis of Potential Differences in Disease
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2014
Impact of chemotherapy on normal tissue complication probability models of acute hematologic
International journal of radiation oncology, biology, physics, 2013
Long-Term Outcomes of Surgery Followed by Radiation Therapy for Minor Salivary Gland Carcinomas
LARYNGOSCOPE, 2013
Safety of (90)y radioembolization in patients who have undergone previous external beam radiation
International journal of radiation oncology, biology, physics, 2013
Radiotherapy for nonadenoid cystic carcinomas of major salivary glands.
American journal of otolaryngology, 2013
Seventh Edition (2010) of the AJCC
ANNALS OF SURGICAL ONCOLOGY, 2013
A Phase 2 Multi-institutional Study to Evaluate Gemcitabine
Practical radiation oncology, 2013
Dosimetric analysis of organs at risk during expiratory gating
International journal of radiation oncology, biology, physics, 2013
Chemoradiotherapy Before and After Surgery for Locally Advanced Esophageal Cancer
Annals of surgical oncology
Metabolic Tumor Volume Predicts Disease Progression
JOURNAL OF NUCLEAR MEDICINE, 2013
Signet Ring Cell Colorectal Carcinoma
The American journal of surgical pathology
Clinicopathologic Features of Synchronous Colorectal Carcinoma
The American journal of surgical pathology
Future directions in combined modality therapy for rectal cancer
ONCOTARGETS AND THERAPY, 2013
SBRT as a Novel Treatment Option for Locally Recurrent Pancreatic Cancer After Failure of
Wild, A., Hiniker, S. M., LIMAYE, M. R., Chang, D. T., Laheru, D. A., , 2012
Normal Tissue Complication Probability Modeling of Acute Hematologic Toxicity
Bazan, J. G., Luxton, G., Mok, E. C., Koong, A. C., Chang, D. T., 2012
Normal Tissue Complication Probability Modeling of Acute Hematologic Toxicity
Bazan, J. G., Luxton, G., Kozak, M. M., Anderson, E. M., Hancock, S. L, 2012
Postchemoradiotherapy Positron Emission Tomography Predicts Pathologic Response
Jayachandran, P., Pai, R. K., Quon, A., Graves, E., Krakow, T. E., La,, 2012
Esophageal tolerance to high-dose stereotactic ablative radiotherapy
DISEASES OF THE ESOPHAGUS, 2012
Positron Emission Tomography for Predicting Pathologic Response
Chennupati, S. K., Quon, A., Kamaya, A., Pai, R. K., La, T., Krakow, T, 2012
Intrafraction Verification of Gated RapidArc by Using Beam-Level Kilovoltage X-Ray Images
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012
Prognostic Value of Metabolic Tumor Volume and Velocity in Predicting Head-and-Neck Cancer Outcomes
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012
Combined Modality Therapy for Rectal Cancer
ANNALS OF SURGICAL ONCOLOGY, 2012
Clinicopathologic and molecular features of sporadic early-onset colorectal adenocarcinoma
MODERN PATHOLOGY, 2012
Orthovoltage Intraoperative Radiotherapy for Locally Advanced and Recurrent Colorectal Cancer
DISEASES OF THE COLON & RECTUM, 2012
A phase II multi-institutional study to evaluate gemcitabine
Herman, J. M., Chang, D. T., Goodman, K. A., Wild, A. T., Laheru, D.,
Intensity-Modulated Radiotherapy for Tumors of the Nasal Cavity and Paranasal Sinuses
Wiegner, E. A., Daly, M. E., Murphy, J. D., Abelson, J., Chapman, C. H, 2012
BRAF-mutated, Microsatellite-stable Adenocarcinoma of the Proximal Colon
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2012
Intensity-Modulated Radiotherapy for Pancreatic Adenocarcinoma
Abelson, J. A., Murphy, J. D., Minn, A. Y., Chung, M., Fisher, G. A., , 2012
Modern Radiation Therapy Techniques for Pancreatic Cancer
GASTROENTEROLOGY CLINICS OF NORTH AMERICA, 2012
Cost-effectiveness of modern radiotherapy techniques in locally advanced pancreatic cancer
CANCER, 2012
HER2 Expression in Gastric and Gastroesophageal Junction Adenocarcinoma in a US Population
APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2012
Combined-modality Therapy for Rectal Cancer
American journal of clinical oncology
A rare case of an aldosterone secreting metastatic adrenocortical carcinoma
Rare tumors, 2011
SINGLE-FRACTION STEREOTACTIC BODY RADIATION THERAPY AND SEQUENTIAL GEMCITABINE FOR THE TREATMENT OF
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011
Stereotactic Body Radiotherapy for Colorectal Liver Metastases A Pooled Analysis
CANCER, 2011
Intensity-Modulated Radiation Therapy Versus Conventional Radiation Therapy for Squamous Cell
CANCER, 2011
INTENSITY-MODULATED RADIOTHERAPY FOR ORAL CAVITY SQUAMOUS CELL CARCINOMA
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011
Rectal and bladder deformation and displacement during preoperative radiotherapy for rectal cancer
Practical radiation oncology, 2011
PROSPECTIVE RANDOMIZED DOUBLE-BLIND PILOT STUDY OF SITE
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011
Pattern of Lymph Node Involvement and Prognosis in Pancreatic Adenocarcinoma
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2011
INTENSITY-MODULATED RADIOTHERAPY FOR LOCALLY ADVANCED CANCERS OF THE LARYNX AND HYPOPHARYNX
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND, 2011
Gastrointestinal Normal Tissue Toxicity Prediction In Stereotactic Body Radiotherapy
Murphy, J. D., Abelson, J., Chung, M. P., Chang, D. T., Koong, A. C., 2011
Multimodality Therapy for Esophageal Cancer: The Benefit of Chemoradiation
Vossler, S. R., Bavan, B., Kunz, P., Ford, J. M., Fisher, G. A., Whyte, 2011
Radiotherapy For Adenoid Cystic Carcinomas Of The Head and Neck
Shultz, D. B., Murphy, J. D., Daly, M. E., Hara, W., Le, Q. T., Chang,, 2011
Dosimetric Comparison of RapidArc versus CyberKnife for Stereotactic Body Radiation Therapy for
Atwood, T. F., Mok, E., Lo, A., Xing, L., Koong, A. C., Chang, D. T., 2011
Stereotactic Body Radiation Therapy for Gastrointestinal Malignancies
IMRT IGRT SBRT- ADVANCES IN THE TREATMENT PLANNING AND DELIVERY OF RAD, 2011
A DOSIMETRIC MODEL OF DUODENAL TOXICITY AFTER STEREOTACTIC BODY RADIOTHERAPY FOR PANCREATIC CANCER
Murphy, J. D., Christman-Skieller, C., Kim, J., Dieterich, S., Chang, , 2010
Expression of p16(INK4A) But Not Hypoxia Markers or Poly Adenosine Diphosphate
Chang, D. T., Chapman, C. H., Norton, J. A., Visser, B., Fisher, G. A., 2010
Orthovoltage intraoperative radiation therapy for pancreatic adenocarcinoma
RADIATION ONCOLOGY, 2010
Comparison of Intensity-Modulated Radiotherapy
Minn, A. Y., Hsu, A., La, T., Kunz, P., Fisher, G. A., Ford, J. M., No, 2010
(18)FLUORODEOXYGLUCOSE PET IS PROGNOSTIC OF PROGRESSION
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010
Pathological response after chemoradiation for T3 rectal cancer.
Colorectal disease, 2010
Pathological response after chemoradiation for T3 rectal cancer
COLORECTAL DISEASE, 2010
INTENSITY-MODULATED RADIOTHERAPY IN THE TREATMENT OF OROPHARYNGEAL CANCER
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010
EUS-guided gold fiducial insertion for image-guided radiation therapy of pancreatic cancer
GASTROINTESTINAL ENDOSCOPY, 2010
INTERFRACTIONAL UNCERTAINTY IN THE TREATMENT OF PANCREATIC CANCER WITH RADIATION
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010
Multimodality treatment with intensity modulated radiation therapy for esophageal cancer
DISEASES OF THE ESOPHAGUS, 2010
Stereotactic Body Radiotherapy for Colorectal Liver Metastases: A Pooled Analysis
Chang, D. T., Swaminath, A., Kozak, M., Weintraub, J., Koong, A. C., K, 2010
Prognostic Value of Metabolic Tumor Volume and Velocity in Predicting Head and Neck Cancer Outcomes
Chu, K. P., Murphy, J., La, T. H., Loo, B. W., Krakow, T. E., Hsu, A.,, 2010
Combined Modality Therapy for Rectal Cancer
Liauw, S., Song, S., Tonlaar, N., Hong, J. C., Minsky, B. D., Chang, D, 2010
Significant Duodenal Dose Variation within the Respiratory Cycle during Stereotactic Body
Taniguchi, C. M., Kielar, K. N., Murphy, J. D., Atwood, T. F., Christm, 2010
Comparison of RapidArc vs. Conventional Intensity Modulated Radiation Therapy
Kielar, K. N., Atwood, T. F., Taniguchi, C. M., Christman-Skieller, C., 2010
Intensity Modulated Radiation Therapy vs. Conventional Radiation Therapy
Bazan, J. G., Hara, W., Kunz, P., Fisher, G. A., Ford, J. M., Welton, , 2010
Identification of a biomarker panel using a multiplex proximity ligation
JOURNAL OF TRANSLATIONAL MEDICINE, 2009
Pharmacologically Increased Tumor Hypoxia Can Be Measured by F-18
CLINICAL CANCER RESEARCH, 2009
Pancreatic Tumor Motion on a Single Planning 4D
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2009
Treatment of Esophageal Cancer Based on Histology A Surveillance Epidemiology
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2009
Long-term Outcomes for Stage I-II Aggressive Non-Hodgkin Lymphoma of Waldeyer's Ring
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2009
Percutaneous Implantation of Fiducial Markers for Imaging-Guided Radiation Therapy
AMERICAN JOURNAL OF ROENTGENOLOGY, 2009
Xerostomia in Long-term Survivors of Aggressive Non
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2009
Safety and Efficacy of Percutaneous Fiducial Marker Implantation for Image-guided Radiation Therapy
JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY, 2009
Stereotactic Radiotherapy for Unresectable Adenocarcinoma of the Pancreas
CANCER, 2009
A Prospective Randomized Pilot Study of Site
Fuller, C. D., Duppen, J., Rasch, C. R., Kachnic, L., Wang, S. J., Cha, 2009
Stereotactic body radiotherapy for unresectable adenocarcinoma of the pancreas
Chang, D. T., Schellenberg, D., Shen, J., Kim, J., Goodman, K., Fisher, 2008
Do pre-irradiation dental extractions reduce the risk of osteoradionecrosis of the mandible?
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND, 2007
Long-term outcomes in breast cancer patients with ten or more positive axillary nodes treated with
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2007
Predicting changes in dose distribution to tumor
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2007
Adjuvant radiotherapy for cutaneous melanoma
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2006
The impact of heterogeneity correction on dosimetric parameters that predict
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2006
Re-examining the role of elective nodal irradiation
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2005
Merkel cell carcinoma of the skin with leptomeningeal metastases
AMERICAN JOURNAL OF OTOLARYNGOLOGY, 2005
Role of p53 in cell cycle regulation and apoptosis following exposure to proteasome inhibitors
CELL GROWTH & DIFFERENTIATION, 2000
Dose-dependent effects of DNA-damaging agents on p53-mediated cell cycle arrest
CELL GROWTH & DIFFERENTIATION, 1999
What is Dr. Chang's NPI number?An National Provider Identifier (NPI) is a unique ID number that identifies doctors and healthcare providers nationwide.
Dr. Chang's National Provider Identifier (NPI) number is 1285722892.
What common questions do patients ask about Dr. Chang?
Here are answers to patients Frequently Asked Questions (FAQ’s) about Dr. Chang
What is Dr. Daniel Chang's specialty?
Dr. Chang is a Radiation Oncologist near Ann Arbor, MI. A radiological oncologist specializes in the therapeutic applications of radiant energy and its modifiers. They focus on the study and management of diseases, particularly malignant tumors. Contact Dr. Chang to book an appointment today.
Is this Dr. Daniel Chang affiliated with a ranked Castle Connolly Top Hospital?
No, Chang is not affiliated with a Castle Connolly Top Hospital, but is affiliated with the following hospitals: University Of Michigan Health - University Hospital. Castle Connolly Top Hospitals are identified through a rigorous peer nomination process, evaluating factors like patient outcomes, quality of care, and expertise. The list recognizes hospitals that excel in 20 or more specific medical procedures, representing the top 25% nationwide. Castle Connolly Top Hospitals
Where can I learn more about Radiation Oncologist?
Explore Radiation Oncologist with insights from trusted medical experts on EverydayHealth.com, where you'll find the most relevant content and helpful condition guides for up-to date information about symptoms, causes, diagnosis, treatment and more. See all our health guides to find trusted information on medical conditions from our experts at Everyday Health.
Is Daniel Chang accepting new patients in Ann Arbor, MI?
Yes, Dr. Daniel Chang is accepting new patients at this time.
Does Dr. Daniel Chang offer online booking?
Please contact Dr. Chang's office at (650) 736-7143 for information about online booking, telehealth, or to schedule an appointment.
How can I make an appointment with Daniel Chang?
Please contact Dr. Chang's office at (650) 736-7143 for information regarding telehealth appointment availability or for scheduling assistance.
Which board certifications does Dr. Daniel Chang have?
Dr. Daniel Chang is certified by the American Board of Radiology.
Other Radiation Oncologist Near Ann Arbor, MI
Radiation Oncologist
Accepting patientsRadiation Oncologist
Accepting patients